EDGAR Filing Documents for 0001104659-15-045417

Form 8-K - Current report:

SEC Accession No. 0001104659-15-045417

Filing Date

2015-06-15

Accepted

2015-06-15 16:45:24

Documents

Period of Report

2015-06-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-13693_28k.htm	8-K	51575
2	EX-1.1	a15-13693_2ex1d1.htm	EX-1.1	378219
3	EX-4.1	a15-13693_2ex4d1.htm	EX-4.1	844723
4	GRAPHIC	g136932ki11i001.jpg	GRAPHIC	1155
5	GRAPHIC	g136932ki11i002.jpg	GRAPHIC	1649
6	GRAPHIC	g136932ki09i001.jpg	GRAPHIC	1133
7	GRAPHIC	g136932ki09i002.jpg	GRAPHIC	1302
8	GRAPHIC	g136932ki09i003.jpg	GRAPHIC	1292
9	GRAPHIC	g136932ki09i004.jpg	GRAPHIC	1274
	Complete submission text file	0001104659-15-045417.txt		1287442

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142

Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722

IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 15931665
SIC: 2834 Pharmaceutical Preparations